宋恩峰教授从肺、脾、肾三脏论治肺癌
Professor Song Enfeng Treats Lung Cancer from the Lung, Spleen and Kidney
DOI: 10.12677/TCM.2023.129410, PDF,   
作者: 郝傲寒:湖北中医药大学中医临床学院,湖北 武汉;宋恩峰*:武汉大学人民医院中医科,湖北 武汉
关键词: 肺癌本虚标实辩证论治治疗经验Lung Cancer Difficiency in Origin and Excess in Superficiality Dialectical Treatment Treatment Experience
摘要: 肺癌在中国是患病率和死亡率最高的恶性肿瘤。宋恩峰教授根据古今医家认识及多年临床经验认为肺癌病因为机体脏腑亏虚,正气不足,邪毒乘虚而入,痰瘀互结蕴于肺脏,日久引发癌病。病机总属本虚标实,论其本虚多指肺脾肾三脏的亏虚,标实为痰瘀毒邪于机体内作祟。提出临床中应分辨肺癌的整体征象,治疗时注重调补脏腑功能,配合肺脾肾的生理特性用药。现总结宋恩峰教授论治肺癌的学术思想,对宋教授治疗肺癌的临床思路与遣方用药经验进行探析。
Abstract: In China, lung cancer is a malignant tumor with the highest prevalence and mortality. According to ancient doctor family understanding and many years of clinical experience, professor Song Enfeng believed that lung cancer disease was caused by the deficient internal organs, insufficient Qi, multiplicity and deficiency of evil toxins, mutual accumulation of phlegm and stasis in the lungs, and daily initiation of cancer disease. The pathogenic mechanism is attributed to the essence of Ben deficiency, which refers to the deficiency of lung spleen and kidney in three cases, and the standard practice is that phlegm and stasis poison is found in the body. It is suggested that in clinical practice, the overall symptoms of lung cancer should be distinguished, and the treatment should focus on regulating and tonifying viscera functions, and taking medicines in accordance with the physiological characteristics of the lung, spleen and kidney. This article summarizes professor Song Enfeng’s academic thinking on the treatment of lung cancer, and explores professor Song’s clinical thinking and experience in prescriptions and medications in the treatment of lung cancer.
文章引用:郝傲寒, 宋恩峰. 宋恩峰教授从肺、脾、肾三脏论治肺癌[J]. 中医学, 2023, 12(9): 2734-2738. https://doi.org/10.12677/TCM.2023.129410

参考文献

[1] Zheng, R., Zhang, S., Zeng, H., et al. (2022) Cancer Incidence and Mortality in China, 2016. Journal of the National Cancer Center, 2, 1-9. [Google Scholar] [CrossRef] [PubMed]
[2] 张海璐, 刘宇恒. 中医药治疗肺癌临床研究进展[J]. 内蒙古中医药, 2023, 42(4): 156-158.
[3] 王琦苑, 秦丹梅, 李金彩, 等. 从“内风”探讨中医对恶性肿瘤转移的认识[J]. 中西医结合研究, 2016, 8(5): 273-274
[4] 郭乃燕. 补益类中药与抗癌[J]. 时珍国药研究, 1998, 9(2): 191.
[5] 徐力. 《理虚元鉴》虚劳治疗总纲探析[J]. 陕西中医学院学报, 1997, 20(1): 49, 36.
[6] 梅雪峰, 鲍奇勇. 浅论“肺体属金, 非叩不鸣” [J]. 河南中医, 2011, 31(11): 1319.
[7] 董洪珍, 张伟, 郑洋. 五脏相关理论之肺脾相关理论的实验研究总结和探讨[J]. 辽宁中医杂志, 2016, 43(2): 274-275.
[8] 姜璇, 袁红霞, 丁沛, 等. 从“脾胃气机”角度浅探旋覆代赭汤治疗反流性食管炎作用机理[J]. 辽宁中医杂志, 2013, 40(12): 2460-2462.
[9] 赵敏, 周艳艳, 陈会敏, 徐安莉. “肺肾相关”的理论探讨[J]. 湖北中医药大学学报, 2013, 15(6): 38-39.
[10] 游琼, 彭素娟. 袁长津教授痰瘀同治法治疗肺癌的临床经验[J]. 山西中医药大学学报, 2022, 23(6): 587-589, 593.
[11] 程海波, 吴勉华. 周仲瑛教授“癌毒”学术思想探析[J]. 中华中医药杂志. 2010, 25(6): 866-869.
[12] 崔晓丽, 姜云香. 培土生金法在呼吸系统疾病中的应用[J]. 中医药临床杂志, 2005, 17(6): 532-534.
[13] 陈新立, 王志光. 健脾益肾化痰方联合DP方案化疗治疗中晚期肺鳞癌的疗效分析[J]. 广西医科大学学报, 2021, 38(10): 1985-1989.
[14] 臧传龙. 真武汤联合吉非替尼治疗脾肾阳虚型肺腺癌的疗效观察[D]: [硕士学位论文]. 青岛: 青岛大学, 2021.[CrossRef
[15] 桂颖. 百合固金汤加味治疗晚期非小细胞肺癌的临床研究[J]. 中医临床研究, 2011(18): 15-16.